drugset / Trial / NCT01736527

Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation

NCT01736527

Phase 1 Completed 12 enrolled Bausch & Lomb Incorporated
NaSingle-groupOpen-label

Summary

To assess the levels of loteprednol etabonate (LE) in tear fluid following a single topical instillation of LE ophthalmic gel 0.5% formulation to healthy volunteers.

Timeline

Start
2013-01
Primary completion
2013-01
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Loteprednol Etabonate Other / unclassified 0.5 % Topical

Indications

No indication recorded.